News

Recommended headache treatments get mixed reception in EDs

Author:

Randy Dotinga

Opioid prescriptions have declined but guideline-supported triptans and corticosteroids aren’t filling the gap.

• Read More

Opinion

Patients with blood cancers underutilize palliative care

Author:

Sarah F. D’Ambruoso, NP

Today in “Diminutio,” Sarah D’Ambruoso, NP, highlights this and other key presentations on palliative care from the ASCO annual meeting.

• Read More

Article

SBRT plus TACE better than monotherapy in HCC with portal vein tumor thrombus

• Read More

Article

Unresectable HCC: Differential efficacy of atezolizumab plus bevacizumab according to hepatic function grade

• Read More

Article

Atezolizumab plus bevacizumab offers a better prognosis than lenvatinib in unresectable HCC

• Read More

Article

HCC with Child-Pugh B cirrhosis: Nivolumab a promising first-line systemic treatment option

• Read More

Article

Preoperative ratio of creatinine and cystatin C estimated glomerular filtration rates predicts survival outcomes after hepatic resection for HCC

• Read More

Article

C reactive protein to albumin ratio predicts survival outcomes in lenvatinib-treated patients with unresectable HCC

• Read More

Article

NAFLD significantly increases the risk for HCC

• Read More

Article

Microwave ablation bridges patients with HCC to liver transplant

• Read More